STORM Therapeutics Ltd

Who: Johnson & Johnson / Remix Therapeutics What: The two companies signed a deal to develop small molecule drugs that modulate RNA processing using Remix’s REMaster drug discovery platform, partic

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Alliances With F-star And Xencor Featur

Who: Exelixis/Storm Therapeutics; Exelixis/Aurigene Discovery What: Exelixis partners with Storm on RNA-modifying enzyme therapies for cancer; the biotech also licenses a non-Hodgkin’s lymphoma can

“If you look at the corporate venture capital world we’re all structured differently, there’s no two of us that are alike,” Pfizer Ventures’ senior managing partner Barbara Dalton, who has run the gro